Lorne SteinbergGE HealthCareGEHCWAITOct 20, 2023

He owns a big position. Likes this a lot and it's doing many great things. It's so cheap. Is sticking with this long-term. Likes their business which is MRIs.

Spun out from GE. He's been buying it this year and holds a large position. They reported a great beat in late July. Eventually, GEHC will decouple from the rest of healthcare which has been lagging. (Maybe Wall St is nervous about Washington taking shots at healthcare in the election year coming up.) Shares are down 12% this month, and this is a cheap, great opportunity.

This GE health spin-off's equipment will be in big demand next year when doctors conduct MRIs to measure plaque in the brain (to determine which patients get the new Alzheimer's drug). Huge demand. Why are shares down 12 points since their report. Makes no sense. He bought more shares to average down.

Getting good reviews. He's done some research into it. It's screening quite well, there's some opportunity here. A good healthcare offering.

He's been buying it. You will need an MRI before you can get into an Alzheimer's program. GEHC will have to talk about AI in their business when they report next week.

He bought it last week. Has more room to run. Spunoff by GE to start the year. Is up 35% YTD. Their scanners catch Alzheimer's. He's bullish on medical devices. Trades at 18x 2024 PE. Is in a slight pullback now.